Obinutuzumab is a prescription medication used to treat patients with chronic lymphocytic leukemia (CLL) or follicular lymphoma. Obinutuzumab belongs to a group of drugs called monoclonal antibodies. These work by helping the body slow or stop the growth of cancer cells.
This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.
Common side effects of obinutuzumab include infusion reactions, fever, and cough.